Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.23 -0.04 (-0.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Interest & Investment Income (2020 - 2026)

Updated

Olema Pharmaceuticals' Interest & Investment Income came in at $4.51 million for Q2 2026, up 11.5% from $4.04 million a year earlier but down 5.6% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Interest & Investment Income (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Olema Pharmaceuticals reported Interest & Investment Income of $16.94 million, up 14.6% year-over-year; for FY2025, it came in at $16.22 million, up 27.9% from FY2024.

  • Interest & Investment Income has increased in each of the last six years, with a five-year compound annual growth rate of 206.5% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $12.68 million in FY2024 (+52.3%), $8.33 million in FY2023 (+273.7%), $2.23 million in FY2022 (+404.1%) and $442,000 in FY2021 (+636.7%).
  • The five-year range for quarterly Interest & Investment Income is $105,000 (Q3 2021) to $4.78 million (Q1 2026).
  • Year-over-year, Interest & Investment Income has increased for six consecutive quarters, with growth averaging 21.7% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q4 2022 (growth of 792.7%), and the weakest in Q4 2024 (a decline of 7.2%).
  • Business Quant data shows OLMA's Interest & Investment Income at $4.78 million (Q1 2026), $4.01 million (Q4 2025) and $3.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Olema Pharmaceuticals 719.73 Mn 719.73 Mn - 4.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.51 Mn
Mar 31, 2026 4.78 Mn
Dec 31, 2025 4.01 Mn
Sep 30, 2025 3.65 Mn
Jun 30, 2025 4.04 Mn
Mar 31, 2025 4.52 Mn
Dec 31, 2024 3.29 Mn
Sep 30, 2024 2.93 Mn
Jun 30, 2024 3.11 Mn
Mar 31, 2024 3.35 Mn
Dec 31, 2023 3.55 Mn
Sep 30, 2023 1.92 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.31 Mn
Dec 31, 2022 973,000.00
Sep 30, 2022 622,000.00
Jun 30, 2022 415,000.00
Mar 31, 2022 218,000.00
Dec 31, 2021 109,000.00
Sep 30, 2021 105,000.00
API Access

Olema Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OLMA&period=max&api_key=YOUR_API_KEY